News

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...
However, there is finally an excellent reason to shell out for an RTX 50 series graphics card, and it is all thanks to Doom. For a limited time, customers who purchase an eligible graphics card, ...
cn-font-split 是 中文网字计划 所使用的字体分包工具,通过高性能的各种技术将庞大的字体包拆分为适合网络分发的版本 ...
Downey is playing Doctor Doom, the man antagonist in the film who will be facing off against an ensemble of some of the MCU's biggest heroes. However, it's not the only role that he's playing, ...
Nvidia’s got your back where that’s concerned. The company just announced a new DOOM: The Dark Ages bundle that gives you the game for free when buying one of Nvidia’s latest GPUs.
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...
In a twist no one saw coming, the first set photo reveals Robert Downey Jr., the face of Iron Man as Doctor Doom. While previously, RDJ was only confirmed as the villainous Doom, the photos now give ...
The lawyer called on the Kenyan voters not to entrust them with power as an alternative to Ruto. "That is the ‘Doom Team’ which Freedom Fighters must bury, together with President William Ruto," ...
In celebration of the 30th anniversary of Asus graphics cards, and the upcoming release of Doom The Dark Ages, Bethesda and Asus are partnering up to unleash a limited edition graphics card based ...
TL;DR: ASUS and Bethesda launched the limited-edition ROG Astral GeForce RTX 5080 DOOM Edition graphics card, featuring NVIDIA Blackwell architecture, 16GB GDDR7 memory, and advanced cooling.
The research, done by the universities of Exeter and Hamburg, analysed several tipping points, which includes the collapse of Greenland and Antarctic ice sheets and loss of mountain glaciers. The team ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...